Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
33m
2seventy Bio stops enrolling patients in blood cancer therapy study
The decision was taken due to the fewer number of eligible patients amid increasing treatment options than when the study was first designed, Anna Truppel-Hartmann, chief medical officer of 2seventy ...
Targeted Oncology
41m
What Impact Will GLP-1 Agonists Have on Cancer?
GLP-1 agonists, widely used for obesity and diabetes management, have been associated with a reduced risk of most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Would-be assassin charged
Penn suspends law professor
Campaign office damaged
School book bans surge
Woman dies in 'suicide pod’
Texas AG appeal denied
Calls strike against 'LoL’
US to waive visas for Qatar
Briefed on Iranian threats
Chemical leak in OH county
InfoWars to be auctioned off
CA new gun control laws
Study: Myopia on the rise
Storm Helene strengthens
China conducts ICBM test
NYC schools boss retiring
Gets 2-yrs for role in fraud
Union gets more voting time
Pac-12 sues Mountain West
Johnny Cash statue unveiled
X account hacked
$375M military aid to UKR
ISR: Hezbollah leader killed
Rioter mistakenly released
‘Trump Train’ jury verdict
Executed by lethal injection
PA county ballot ruling
Hezbollah missile intercepted
Related topics
Sanofi
Food and Drug Administration
Sarclisa
isatuximab
Feedback